{"transactions":[{"id":731809,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T21:32:39.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2027 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2029. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":75000,"derivative":{"exercise_price":9.42,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193125-26-276149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000119312526276149/ownership.xml","form_type":"4"}},{"id":749424,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:21:56.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":223492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":223492,"derivative":{"exercise_price":1.58,"exercise_date":"2026-07-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":223492},"source":{"system":"sec-edgar","filing":"0001299130-26-000096","document":"wk-form4_1780608113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913026000096/wk-form4_1780608113.xml","form_type":"4"}},{"id":804370,"issuer":{"id":4435,"kind":"organization","name":"Kailera Therapeutics, Inc.","symbol":"KLRA"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-20T21:13:40.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":38300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable as to 100% of the underlying shares on April 16, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":38300,"derivative":{"exercise_price":16,"expiration_date":"2036-04-16","underlying":"Common Stock","underlying_shares":38300},"source":{"system":"sec-edgar","filing":"0001193125-26-164271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000119312526164271/ownership.xml","form_type":"4"}},{"id":1104805,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:03:35.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2026 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2028. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":33750,"derivative":{"exercise_price":4.15,"expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0000950170-25-088484","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000095017025088484/ownership.xml","form_type":"4"}},{"id":1119426,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:07:29.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":65000,"derivative":{"exercise_price":1.03,"exercise_date":"2025-07-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001299130-25-000133","document":"wk-form4_1749240442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000133/wk-form4_1749240442.xml","form_type":"4"}},{"id":1473004,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:58:44.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":32179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":32179,"derivative":{"exercise_price":1.65,"exercise_date":"2024-07-18","expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":32179},"source":{"system":"sec-edgar","filing":"0001299130-24-000152","document":"wk-form4_1718917116.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000152/wk-form4_1718917116.xml","form_type":"4"}},{"id":1473003,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:58:44.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":22821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest on the one (1) year anniversary of the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":132821,"source":{"system":"sec-edgar","filing":"0001299130-24-000152","document":"wk-form4_1718917116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000152/wk-form4_1718917116.xml","form_type":"4"}},{"id":1503433,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2024-05-23T23:11:06.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":26791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 21, 2025 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 21, 2027. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":26791,"derivative":{"exercise_price":25.15,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":26791},"source":{"system":"sec-edgar","filing":"0000950170-24-064210","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000095017024064210/ownership.xml","form_type":"4"}},{"id":1876292,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-26T21:00:19.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":25775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":25775,"derivative":{"exercise_price":11.94,"exercise_date":"2023-06-24","expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":25775},"source":{"system":"sec-edgar","filing":"0001299130-23-000084","document":"wf-form4_168513479461225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913023000084/wf-form4_168513479461225.xml","form_type":"4"}},{"id":1877810,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T23:42:12.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2024 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2026. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":33750,"derivative":{"exercise_price":17.98,"expiration_date":"2033-05-22","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0001610717-23-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000161071723000073/form4.xml","form_type":"4"}},{"id":2253099,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T23:27:05.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":63015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":63015,"derivative":{"exercise_price":5.37,"exercise_date":"2022-06-25","expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":63015},"source":{"system":"sec-edgar","filing":"0001299130-22-000081","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913022000081/certent-form4.xml","form_type":"4"}},{"id":2256491,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T23:05:15.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":33750,"derivative":{"exercise_price":7.77,"expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0001567619-22-011721","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000156761922011721/doc1.xml","form_type":"4"}},{"id":2660676,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T01:18:47.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":12885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":12885,"derivative":{"exercise_price":27.9,"exercise_date":"2021-07-16","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":12885},"source":{"system":"sec-edgar","filing":"0001299130-21-000176","document":"certent-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913021000176/certent-form4.xml","form_type":"4"}},{"id":2705111,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T00:33:16.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":11250,"derivative":{"exercise_price":26.89,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001567619-21-010748","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000156761921010748/doc1.xml","form_type":"4"}},{"id":2705110,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T00:33:16.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":26.89,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001567619-21-010748","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000156761921010748/doc1.xml","form_type":"4"}},{"id":2939706,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T22:40:40.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":100000,"price":23,"value":2300000.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John F Milligan & Kathryn Bradford Milligan Trust."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001567619-20-021289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191589/000156761920021289/doc1.xml","form_type":"4"}},{"id":3003986,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-19T20:11:36.000Z","date":"2020-10-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next two years, provided that the Reporting Person continues to serve through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":14.34,"exercise_date":"2021-10-15","expiration_date":"2030-10-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-055259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120055259/doc4.xml","form_type":"4"}},{"id":3046201,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.61,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046200,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.81,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046199,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.45,"expiration_date":"2024-05-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046198,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option were fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.67,"expiration_date":"2023-07-17","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046197,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":25000,"price":2.61,"value":65250.0,"ownership":{"direct":true},"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046196,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":25000,"price":3.81,"value":95250.0,"ownership":{"direct":true},"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046195,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":25000,"price":4.45,"value":111250.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3046194,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T23:29:55.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":35000,"price":2.67,"value":93450.0,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-20-048447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120048447/doc4.xml","form_type":"4"}},{"id":3065767,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-06T22:46:12.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":97785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period, or if earlier, on the date of the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director through each vesting date."}],"balance_after":97785,"derivative":{"exercise_price":3.89,"exercise_date":"2020-09-04","expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":97785},"source":{"system":"sec-edgar","filing":"0001209191-20-045571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919120045571/doc4.xml","form_type":"4"}},{"id":410475,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-11-30T01:42:18.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001127602-18-034776","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218034776/form4.xml","form_type":"4"}},{"id":410474,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-30T01:42:18.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":280000,"price":23.6,"value":6608000.0,"ownership":{"direct":true},"balance_after":1574306,"source":{"system":"sec-edgar","filing":"0001127602-18-034776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218034776/form4.xml","form_type":"4"}},{"id":3920314,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-23T20:18:57.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period."}],"balance_after":25000,"derivative":{"exercise_price":2.61,"exercise_date":"2018-06-22","expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-032585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919118032585/doc4.xml","form_type":"4"}},{"id":415196,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-05-08T22:29:17.000Z","date":"2018-05-04","kind":"exercise","acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":27.07,"expiration_date":"2018-05-07","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001127602-18-016673","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218016673/form4.xml","form_type":"4"}},{"id":415195,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-08T22:29:17.000Z","date":"2018-05-04","kind":"exercise","acquired":true,"shares":80000,"price":27.07,"value":2165600.0,"ownership":{"direct":true},"balance_after":1294306,"source":{"system":"sec-edgar","filing":"0001127602-18-016673","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218016673/form4.xml","form_type":"4"}},{"id":418277,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-24T00:07:17.000Z","date":"2018-02-21","kind":"tax_withholding","acquired":false,"shares":8009,"price":80.69,"value":646246.21,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The amount directly beneficially owned by the Reporting Person is restated to include 223,510 shares that was erroneously categorized as being indirectly owned in prior filings. The reported shares now includes community property shares held in a living trust of which the Reporting Person and his spouse are the sole trustees and sole beneficiaries and as to which the Reporting Person has the unilateral right to withdraw such shares.  The Reporting Person does not beneficially own any shares indirectly."}],"balance_after":1214306,"source":{"system":"sec-edgar","filing":"0001127602-18-008143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008143/form4.xml","form_type":"4"}},{"id":418276,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-24T00:07:17.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":7709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2015. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The amount directly beneficially owned by the Reporting Person is restated to include 223,510 shares that was erroneously categorized as being indirectly owned in prior filings. The reported shares now includes community property shares held in a living trust of which the Reporting Person and his spouse are the sole trustees and sole beneficiaries and as to which the Reporting Person has the unilateral right to withdraw such shares.  The Reporting Person does not beneficially own any shares indirectly."}],"balance_after":1222315,"source":{"system":"sec-edgar","filing":"0001127602-18-008143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008143/form4.xml","form_type":"4"}},{"id":418275,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-24T00:07:17.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":48342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2018 and December 31, 2019, respectively."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The amount directly beneficially owned by the Reporting Person is restated to include 223,510 shares that was erroneously categorized as being indirectly owned in prior filings. The reported shares now includes community property shares held in a living trust of which the Reporting Person and his spouse are the sole trustees and sole beneficiaries and as to which the Reporting Person has the unilateral right to withdraw such shares.  The Reporting Person does not beneficially own any shares indirectly."}],"balance_after":1214606,"source":{"system":"sec-edgar","filing":"0001127602-18-008143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008143/form4.xml","form_type":"4"}},{"id":418274,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-02-24T00:07:17.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":340,"price":62.3475,"value":21198.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The amount directly beneficially owned by the Reporting Person is restated to include 223,510 shares that was erroneously categorized as being indirectly owned in prior filings. The reported shares now includes community property shares held in a living trust of which the Reporting Person and his spouse are the sole trustees and sole beneficiaries and as to which the Reporting Person has the unilateral right to withdraw such shares.  The Reporting Person does not beneficially own any shares indirectly."}],"balance_after":1166264,"source":{"system":"sec-edgar","filing":"0001127602-18-008143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008143/form4.xml","form_type":"4"}},{"id":419639,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-02-06T01:45:22.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":295660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":295660,"derivative":{"exercise_price":83.49,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":295660},"source":{"system":"sec-edgar","filing":"0001127602-18-004152","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004152/form4.xml","form_type":"4"}},{"id":422256,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-11-15T20:19:46.000Z","date":"2017-11-13","kind":"exercise","acquired":false,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a five year vesting schedule. 20% of the options will vest on January 30, 2009, the first anniversary date of the grant.  The balance will vest 5% every three months thereafter until fully vested on January 30, 2013."}],"balance_after":0,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001127602-17-032178","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217032178/form4.xml","form_type":"4"}},{"id":422255,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-15T20:19:46.000Z","date":"2017-11-13","kind":"sale","acquired":false,"shares":220000,"price":72.8849,"value":16034678.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $72.5201 to $73.28.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the Issuer or its shareowners upon request."}],"balance_after":1165924,"source":{"system":"sec-edgar","filing":"0001127602-17-032178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217032178/form4.xml","form_type":"4"}},{"id":422254,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-15T20:19:46.000Z","date":"2017-11-13","kind":"exercise","acquired":true,"shares":220000,"price":21.575,"value":4746500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1385924,"source":{"system":"sec-edgar","filing":"0001127602-17-032178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217032178/form4.xml","form_type":"4"}},{"id":4304586,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-25T21:28:24.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one year period."}],"balance_after":25000,"derivative":{"exercise_price":3.81,"exercise_date":"2017-06-24","expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-035512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299130/000120919117035512/doc4.xml","form_type":"4"}},{"id":429550,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-02-27T23:13:22.000Z","date":"2017-02-23","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a five year vesting schedule. 20% of the options will vest on January 30, 2009, the first anniversary date of the grant.  The balance will vest 5% every three months thereafter until fully vested on January 30, 2013."}],"balance_after":220000,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-17-008707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217008707/form4.xml","form_type":"4"}},{"id":429549,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-27T23:13:22.000Z","date":"2017-02-23","kind":"exercise","acquired":true,"shares":100000,"price":21.575,"value":2157500.0,"ownership":{"direct":true},"balance_after":1165924,"source":{"system":"sec-edgar","filing":"0001127602-17-008707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217008707/form4.xml","form_type":"4"}},{"id":429875,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-22T02:27:57.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":8389,"price":70.31,"value":589830.59,"ownership":{"direct":true},"balance_after":1065924,"source":{"system":"sec-edgar","filing":"0001127602-17-007564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007564/form4.xml","form_type":"4"}},{"id":429874,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-22T02:27:57.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":3429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2014. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":1074313,"source":{"system":"sec-edgar","filing":"0001127602-17-007564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007564/form4.xml","form_type":"4"}},{"id":429873,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-22T02:27:57.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":11606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2015, and February 1, 2016. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2017 and December 31, 2018, respectively."}],"balance_after":1070884,"source":{"system":"sec-edgar","filing":"0001127602-17-007564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007564/form4.xml","form_type":"4"}},{"id":429872,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-22T02:27:57.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":315,"price":59.33,"value":18688.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":1059278,"source":{"system":"sec-edgar","filing":"0001127602-17-007564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217007564/form4.xml","form_type":"4"}},{"id":430869,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-02-07T02:53:00.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":325000,"derivative":{"exercise_price":72.25,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001127602-17-004216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217004216/form4.xml","form_type":"4"}},{"id":435133,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-09-08T17:35:23.000Z","date":"2016-09-06","kind":"exercise","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest over a five year period beginning 5/08/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 5/08/2012."}],"balance_after":0,"derivative":{"exercise_price":20.74,"expiration_date":"2017-05-08","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001127602-16-062200","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216062200/form4.xml","form_type":"4"}},{"id":435132,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-08T17:35:23.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":70000,"price":77.744,"value":5442080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $77.265 to $77.99.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-062200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216062200/form4.xml","form_type":"4"}},{"id":435131,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-08T17:35:23.000Z","date":"2016-09-06","kind":"exercise","acquired":true,"shares":70000,"price":20.74,"value":1451800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1128963,"source":{"system":"sec-edgar","filing":"0001127602-16-062200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216062200/form4.xml","form_type":"4"}},{"id":435992,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-08-03T20:53:44.000Z","date":"2016-08-01","kind":"exercise","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest over a five year period beginning 5/08/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 5/08/2012."}],"balance_after":70000,"derivative":{"exercise_price":20.74,"expiration_date":"2017-05-08","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001127602-16-059418","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059418/form4.xml","form_type":"4"}},{"id":435991,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-08-03T20:53:44.000Z","date":"2016-08-01","kind":"sale","acquired":false,"shares":70000,"price":70.937,"value":4965590.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $79.53 to $80.14.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-059418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059418/form4.xml","form_type":"4"}},{"id":435990,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-08-03T20:53:44.000Z","date":"2016-08-01","kind":"exercise","acquired":true,"shares":70000,"price":20.74,"value":1451800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1128963,"source":{"system":"sec-edgar","filing":"0001127602-16-059418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059418/form4.xml","form_type":"4"}},{"id":436870,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-07-07T18:50:39.000Z","date":"2016-07-05","kind":"exercise","acquired":false,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":16.395,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001127602-16-057737","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057737/form4.xml","form_type":"4"}},{"id":436869,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-07-07T18:50:39.000Z","date":"2016-07-05","kind":"sale","acquired":false,"shares":8630,"price":84.9711,"value":733300.593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $84.79 to $85.12.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-057737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057737/form4.xml","form_type":"4"}},{"id":436868,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-07-07T18:50:39.000Z","date":"2016-07-05","kind":"sale","acquired":false,"shares":103370,"price":84.2761,"value":8711620.457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $83.78 to $84.78.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1067593,"source":{"system":"sec-edgar","filing":"0001127602-16-057737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057737/form4.xml","form_type":"4"}},{"id":436867,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-07-07T18:50:39.000Z","date":"2016-07-05","kind":"exercise","acquired":true,"shares":112000,"price":16.395,"value":1836240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1170963,"source":{"system":"sec-edgar","filing":"0001127602-16-057737","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057737/form4.xml","form_type":"4"}},{"id":437550,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-06-08T22:59:59.000Z","date":"2016-06-06","kind":"exercise","acquired":false,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":112000,"derivative":{"exercise_price":16.395,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001127602-16-055086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216055086/form4.xml","form_type":"4"}},{"id":437549,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-06-08T22:59:59.000Z","date":"2016-06-06","kind":"sale","acquired":false,"shares":59181,"price":87.2589,"value":5164068.9609,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $87.14 to $87.485.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-055086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216055086/form4.xml","form_type":"4"}},{"id":437548,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-06-08T22:59:59.000Z","date":"2016-06-06","kind":"sale","acquired":false,"shares":52819,"price":86.5732,"value":4572709.8508,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $86.13 to $87.13.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1118144,"source":{"system":"sec-edgar","filing":"0001127602-16-055086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216055086/form4.xml","form_type":"4"}},{"id":437547,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-06-08T22:59:59.000Z","date":"2016-06-06","kind":"exercise","acquired":true,"shares":112000,"price":16.395,"value":1836240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1170963,"source":{"system":"sec-edgar","filing":"0001127602-16-055086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216055086/form4.xml","form_type":"4"}},{"id":438759,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-05-04T18:49:43.000Z","date":"2016-05-02","kind":"exercise","acquired":false,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":224000,"derivative":{"exercise_price":16.395,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001127602-16-051073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051073/form4.xml","form_type":"4"}},{"id":438758,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-05-04T18:49:43.000Z","date":"2016-05-02","kind":"sale","acquired":false,"shares":57329,"price":88.1367,"value":5052788.8743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $87.765 to $88.74.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-051073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051073/form4.xml","form_type":"4"}},{"id":438757,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-05-04T18:49:43.000Z","date":"2016-05-02","kind":"sale","acquired":false,"shares":54671,"price":87.2705,"value":4771165.5055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $86.76 to $87.76.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1116292,"source":{"system":"sec-edgar","filing":"0001127602-16-051073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051073/form4.xml","form_type":"4"}},{"id":438756,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-05-04T18:49:43.000Z","date":"2016-05-02","kind":"exercise","acquired":true,"shares":112000,"price":16.395,"value":1836240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1170963,"source":{"system":"sec-edgar","filing":"0001127602-16-051073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051073/form4.xml","form_type":"4"}},{"id":439606,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-04-05T23:30:03.000Z","date":"2016-04-04","kind":"exercise","acquired":false,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":336000,"derivative":{"exercise_price":16.395,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001127602-16-048905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048905/form4.xml","form_type":"4"}},{"id":439605,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-04-05T23:30:03.000Z","date":"2016-04-04","kind":"sale","acquired":false,"shares":15836,"price":94.8752,"value":1502443.6672,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $94.805 to $94.99.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-048905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048905/form4.xml","form_type":"4"}},{"id":439604,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-04-05T23:30:03.000Z","date":"2016-04-04","kind":"sale","acquired":false,"shares":96164,"price":94.5412,"value":9091459.9568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $93.80 to $94.80.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1074799,"source":{"system":"sec-edgar","filing":"0001127602-16-048905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048905/form4.xml","form_type":"4"}},{"id":439603,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-04-05T23:30:03.000Z","date":"2016-04-04","kind":"exercise","acquired":true,"shares":112000,"price":16.395,"value":1836240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1170963,"source":{"system":"sec-edgar","filing":"0001127602-16-048905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048905/form4.xml","form_type":"4"}},{"id":440933,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-03-03T19:54:13.000Z","date":"2016-03-01","kind":"exercise","acquired":false,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":448000,"derivative":{"exercise_price":16.395,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001127602-16-044742","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216044742/form4.xml","form_type":"4"}},{"id":440932,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Common Stock","published_at":"2016-03-03T19:54:13.000Z","date":"2016-03-01","kind":"sale","acquired":false,"shares":112000,"price":87.7946,"value":9832995.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $87.31 to $88.14. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-044742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216044742/form4.xml","form_type":"4"}},{"id":440931,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Common Stock","published_at":"2016-03-03T19:54:13.000Z","date":"2016-03-01","kind":"exercise","acquired":true,"shares":112000,"price":16.395,"value":1836240.0,"ownership":{"direct":true},"balance_after":1170963,"source":{"system":"sec-edgar","filing":"0001127602-16-044742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216044742/form4.xml","form_type":"4"}},{"id":441878,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Common Stock","published_at":"2016-02-19T00:57:17.000Z","date":"2016-02-16","kind":"tax_withholding","acquired":false,"shares":45433,"price":91.15,"value":4141217.95,"ownership":{"direct":true},"balance_after":1058963,"source":{"system":"sec-edgar","filing":"0001127602-16-042273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042273/form4.xml","form_type":"4"}},{"id":441877,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Common Stock","published_at":"2016-02-19T00:57:17.000Z","date":"2016-02-16","kind":"grant","acquired":true,"shares":58794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2013. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":1104396,"source":{"system":"sec-edgar","filing":"0001127602-16-042273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042273/form4.xml","form_type":"4"}},{"id":441876,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Common Stock","published_at":"2016-02-19T00:57:17.000Z","date":"2016-02-16","kind":"grant","acquired":true,"shares":16246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of performance share awards made to the Reporting Person on February 1, 2014, and February 1, 2015. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2016, and committee certifications respectively."}],"balance_after":1045602,"source":{"system":"sec-edgar","filing":"0001127602-16-042273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042273/form4.xml","form_type":"4"}},{"id":441875,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"officer_title":"President, COO and Director"}}],"security":"Common Stock","published_at":"2016-02-19T00:57:17.000Z","date":"2016-02-15","kind":"grant","acquired":true,"shares":248,"price":76.024,"value":18853.952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":1029356,"source":{"system":"sec-edgar","filing":"0001127602-16-042273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042273/form4.xml","form_type":"4"}},{"id":442923,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-02-03T22:44:24.000Z","date":"2016-02-01","kind":"grant","acquired":true,"shares":235820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":235820,"derivative":{"exercise_price":84.05,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":235820},"source":{"system":"sec-edgar","filing":"0001179110-16-018455","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018455/edgar.xml","form_type":"4"}},{"id":444402,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-12-09T19:14:22.000Z","date":"2015-12-07","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.5025,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-15-016040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015016040/edgar.xml","form_type":"4"}},{"id":444401,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-12-09T19:14:22.000Z","date":"2015-12-07","kind":"sale","acquired":false,"shares":39355,"price":103.5571,"value":4075489.6705,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $103.275 to $104.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1029108,"source":{"system":"sec-edgar","filing":"0001179110-15-016040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015016040/edgar.xml","form_type":"4"}},{"id":444400,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-12-09T19:14:22.000Z","date":"2015-12-07","kind":"sale","acquired":false,"shares":60645,"price":102.9349,"value":6242487.0105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $102.27 to $103.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1068463,"source":{"system":"sec-edgar","filing":"0001179110-15-016040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015016040/edgar.xml","form_type":"4"}},{"id":444399,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-12-09T19:14:22.000Z","date":"2015-12-07","kind":"exercise","acquired":true,"shares":100000,"price":14.5025,"value":1450250.0,"ownership":{"direct":true},"balance_after":1129108,"source":{"system":"sec-edgar","filing":"0001179110-15-016040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015016040/edgar.xml","form_type":"4"}},{"id":445146,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-11-12T18:01:43.000Z","date":"2015-11-09","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":100000,"derivative":{"exercise_price":14.5025,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-15-014758","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014758/edgar.xml","form_type":"4"}},{"id":445145,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-11-12T18:01:43.000Z","date":"2015-11-09","kind":"sale","acquired":false,"shares":8509,"price":108.2697,"value":921266.8773,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $108.13 to $108.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1029108,"source":{"system":"sec-edgar","filing":"0001179110-15-014758","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014758/edgar.xml","form_type":"4"}},{"id":445144,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-11-12T18:01:43.000Z","date":"2015-11-09","kind":"sale","acquired":false,"shares":91491,"price":107.5994,"value":9844376.7054,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $107.11 to $108.11. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1037617,"source":{"system":"sec-edgar","filing":"0001179110-15-014758","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014758/edgar.xml","form_type":"4"}},{"id":445143,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-11-12T18:01:43.000Z","date":"2015-11-09","kind":"exercise","acquired":true,"shares":100000,"price":14.5025,"value":1450250.0,"ownership":{"direct":true},"balance_after":1129108,"source":{"system":"sec-edgar","filing":"0001179110-15-014758","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014758/edgar.xml","form_type":"4"}},{"id":445890,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-10-08T18:06:05.000Z","date":"2015-10-07","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":200000,"derivative":{"exercise_price":14.5025,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-15-013939","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013939/edgar.xml","form_type":"4"}},{"id":445889,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-10-08T18:06:05.000Z","date":"2015-10-07","kind":"sale","acquired":false,"shares":34151,"price":99.93,"value":3412709.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $99.57 to $100.26. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1029108,"source":{"system":"sec-edgar","filing":"0001179110-15-013939","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013939/edgar.xml","form_type":"4"}},{"id":445888,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-10-08T18:06:05.000Z","date":"2015-10-07","kind":"sale","acquired":false,"shares":50799,"price":99.084,"value":5033368.116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $98.55 to $99.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1063259,"source":{"system":"sec-edgar","filing":"0001179110-15-013939","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013939/edgar.xml","form_type":"4"}},{"id":445887,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-10-08T18:06:05.000Z","date":"2015-10-07","kind":"sale","acquired":false,"shares":15050,"price":98.0363,"value":1475446.315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $97.52 to $98.49.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1114058,"source":{"system":"sec-edgar","filing":"0001179110-15-013939","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013939/edgar.xml","form_type":"4"}},{"id":445886,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-10-08T18:06:05.000Z","date":"2015-10-07","kind":"exercise","acquired":true,"shares":100000,"price":14.5025,"value":1450250.0,"ownership":{"direct":true},"balance_after":1129108,"source":{"system":"sec-edgar","filing":"0001179110-15-013939","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013939/edgar.xml","form_type":"4"}},{"id":446780,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-09-10T18:57:17.000Z","date":"2015-09-08","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":300000,"derivative":{"exercise_price":14.5025,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-15-013190","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013190/edgar.xml","form_type":"4"}},{"id":446779,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-09-10T18:57:17.000Z","date":"2015-09-08","kind":"sale","acquired":false,"shares":100000,"price":103.3873,"value":10338730.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $102.92 to $103.79.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1029108,"source":{"system":"sec-edgar","filing":"0001179110-15-013190","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013190/edgar.xml","form_type":"4"}},{"id":446778,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-09-10T18:57:17.000Z","date":"2015-09-08","kind":"exercise","acquired":true,"shares":100000,"price":14.5025,"value":1450250.0,"ownership":{"direct":true},"balance_after":1129108,"source":{"system":"sec-edgar","filing":"0001179110-15-013190","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013190/edgar.xml","form_type":"4"}},{"id":447911,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-08-11T20:16:45.000Z","date":"2015-08-07","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":400000,"derivative":{"exercise_price":14.5025,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-15-011974","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011974/edgar.xml","form_type":"4"}},{"id":447910,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-08-11T20:16:45.000Z","date":"2015-08-07","kind":"sale","acquired":false,"shares":3100,"price":115.2784,"value":357363.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $115.23 to $115.30.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1029108,"source":{"system":"sec-edgar","filing":"0001179110-15-011974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011974/edgar.xml","form_type":"4"}},{"id":447909,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-08-11T20:16:45.000Z","date":"2015-08-07","kind":"sale","acquired":false,"shares":22111,"price":114.4444,"value":2530480.1284,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $114.17 to $115.14.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1032208,"source":{"system":"sec-edgar","filing":"0001179110-15-011974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011974/edgar.xml","form_type":"4"}},{"id":447908,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-08-11T20:16:45.000Z","date":"2015-08-07","kind":"sale","acquired":false,"shares":74789,"price":113.7347,"value":8506104.4783,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $113.15 to $114.15.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1054319,"source":{"system":"sec-edgar","filing":"0001179110-15-011974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011974/edgar.xml","form_type":"4"}},{"id":447907,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-08-11T20:16:45.000Z","date":"2015-08-07","kind":"exercise","acquired":true,"shares":100000,"price":14.5025,"value":1450250.0,"ownership":{"direct":true},"balance_after":1129108,"source":{"system":"sec-edgar","filing":"0001179110-15-011974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011974/edgar.xml","form_type":"4"}},{"id":449004,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-07-09T20:20:51.000Z","date":"2015-07-07","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":500000,"derivative":{"exercise_price":14.5025,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-15-011071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011071/edgar.xml","form_type":"4"}},{"id":449003,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16046,"kind":"person","name":"MILLIGAN JOHN F","position":1,"cik":"0001191589","reported_name":"MILLIGAN JOHN F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2015-07-09T20:20:51.000Z","date":"2015-07-07","kind":"sale","acquired":false,"shares":300,"price":116.3833,"value":34914.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Sale prices reported for the transactions reported here range from $116.35 to $116.40.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":1029108,"source":{"system":"sec-edgar","filing":"0001179110-15-011071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011071/edgar.xml","form_type":"4"}}],"next_cursor":"2015-07-09T20:20:51.000000Z,449003"}